Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.85 USD | -0.70% | -0.28% | -45.33% |
May. 08 | Baird Adjusts Price Target on EyePoint Pharmaceuticals to $38 From $46, Keeps Outperform Rating | MT |
May. 08 | Earnings Flash (EYPT) EYEPOINT PHARMACEUTICALS Posts Q1 Revenue $11.7M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-45.33% | 674M | |
+33.20% | 709B | |
+30.77% | 595B | |
-2.29% | 367B | |
+20.20% | 334B | |
+4.88% | 289B | |
+14.32% | 239B | |
+9.07% | 211B | |
-3.44% | 203B | |
+8.47% | 171B |
- Stock Market
- Equities
- EYPT Stock
- News EyePoint Pharmaceuticals, Inc.
- EyePoint Pharmaceuticals Names Jay Duker CEO; Shares Climb